Quantitative Translation in Immuno-Oncology Research and Development

Clin Pharmacol Ther. 2020 Sep;108(3):430-433. doi: 10.1002/cpt.1936. Epub 2020 Jul 9.

Authors

Dean Bottino¹, Rachael Liu¹, Hojjat Bazzazi¹, Karthik Venkatakrishnan²

Affiliations

¹ Millennium Pharmaceuticals, a totally owned subsidiary of Takeda Pharmaceuticals Limited, Cambridge, Massachusetts, USA.
² EMD Serono, Inc., Billerica, Massachusetts, USA.

No abstract available

MeSH terms

Allergy and Immunology*
Animals
Antineoplastic Agents, Immunological / adverse effects
Antineoplastic Agents, Immunological / therapeutic use*
Bayes Theorem
Drug Development*
Humans
Immunotherapy* / adverse effects
Medical Oncology*
Models, Theoretical
Translational Research, Biomedical*

Substances

Antineoplastic Agents, Immunological